Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization
about
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubesCerenkov luminescence imaging of medical isotopes.Id1 restrains p21 expression to control endothelial progenitor cell formation.Astatine Radiopharmaceuticals: Prospects and ProblemsInhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthAn overview of targeted alpha therapy.Radioimmunotherapy with α-particle-emitting radionuclides.Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors.Cancer radioimmunotherapy.A method to predict response of cell populations to cocktails of chemotherapeutics and radiopharmaceuticals: validation with daunomycin, doxorubicin, and the alpha particle emitter (210)Po.Targeted alpha-therapy: past, present, future?Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications.Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression.Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.Remodeling the Vascular Microenvironment of Glioblastoma with α-Particles.Radioimmunotherapy of breast cancer metastases with alpha-particle emitter 225Ac: comparing efficacy with 213Bi and 90Y.Radioimmunotherapy of solid tumors: searching for the right target.Actinium-225 in targeted alpha-particle therapeutic applications.Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives.The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.
P2860
Q28384090-7BC871E6-6D17-4899-9AA3-2F7BCFA29DE9Q30499280-52C575BB-478D-4C0F-BAD1-626260BF9E0AQ33311286-58D8E835-3788-4B8E-B4C1-4D100D6D67C4Q33640550-65FE1B17-4A61-4289-AEF1-7C132E933014Q33915046-726A587B-997C-49F2-AC42-F88691E37D2CQ34238513-E8A5F1B5-77D1-4BC1-843D-F61F9FBA098BQ34419562-E1F95771-7CB7-40A1-95B1-9273233D224FQ34682223-C36DF04E-B3BA-4E7D-9AE3-DD3020A19091Q35070045-4CFDB1EB-8D2E-44B1-84C6-C78E75B94464Q36103417-F3DBE372-F335-4AD2-92DB-6A0CAB5BF805Q36691184-239F38C8-FAC2-4C28-BA08-4C5E7F1A3D50Q36778741-06750A8D-C48B-4EDB-8937-F32C68F88464Q36831312-3C80808F-CE99-4F9B-BE53-D60D05980EE2Q37309920-ACDE1C6D-B07B-4CF3-94EC-5E96CE6C1152Q37389371-3A225628-14F4-4087-AE67-2C3A9CCA262CQ37460994-CA37C9E0-F983-46D2-BA2B-12C0800CD826Q37804904-8BDD0103-771B-44A7-852B-3374CFBF8454Q37971807-EA21C69D-0161-48F4-BDFE-C9ACDB2E2290Q37998372-8537E36C-214B-47F2-941A-BB5B96E8653CQ38028791-496FB696-47AB-4351-81B0-41CC7F589D4A
P2860
Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Selective alpha-particle media ...... re with vascular normalization
@ast
Selective alpha-particle media ...... re with vascular normalization
@en
Selective alpha-particle media ...... re with vascular normalization
@nl
type
label
Selective alpha-particle media ...... re with vascular normalization
@ast
Selective alpha-particle media ...... re with vascular normalization
@en
Selective alpha-particle media ...... re with vascular normalization
@nl
prefLabel
Selective alpha-particle media ...... re with vascular normalization
@ast
Selective alpha-particle media ...... re with vascular normalization
@en
Selective alpha-particle media ...... re with vascular normalization
@nl
P2093
P2860
P1433
P1476
Selective alpha-particle media ...... re with vascular normalization
@en
P2093
Barry J Kappel
Daniel Nolan
David A Scheinberg
Debjit Chattopadhyay
Jaspreet Singh Jaggi
Michael R McDevitt
Robert Benezra
Surya V Seshan
Vivek Mittal
P2860
P356
10.1371/JOURNAL.PONE.0000267
P407
P50
P577
2007-01-01T00:00:00Z